News and Press Releases
New Safety Data Suggests SPRAVATO▼ (Esketamine Nasal Spray) is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder
• The new safety data is from the ESCAPE-TRD Phase 3b study• Additional findings from this study showed esketamine NS demonstrated a significant increase in the proportion of patients achieving...
Category: Clinical Trials, Drug Discovery
Posted: October 9, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Peli BioThermal Exhibit at FlyPharma Europe 2023
Company’s industry leading temperature controlled bulk shipper products and growing global network in the spotlight at European exhibition 6 October 2023 -- Leighton Buzzard, UK -- Peli BioThermal, the life...
Category: Manufacturing and Packing
Posted: October 6, 2023
Phastar Net-Zero Target Approved by the Science Based Targets Initiative
Phastar commits to achieving Net-Zero Standard by 2035 4 October 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), has had...
Category: Drug Discovery
Posted: October 6, 2023
Etihad Cargo Appoints WFS as US-Wide Cargo Handling Agent
Etihad Cargo has appointed Worldwide Flight Services (WFS) as the carrier's cargo handling partner in the US Etihad Cargo's partners and customers will benefit from the cargo handling facilities provided...
Category: Logistics
Posted: October 6, 2023
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring 5 October 2023 -- California, US -- Bio-Rad Laboratories,...
Category: Drug Discovery
Posted: October 5, 2023
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET
Additional Analytical Laboratory and Spray Drying Investments
5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...
Category: Manufacturing and Packing
Posted: October 5, 2023
Gens & Associates launches latest World Class RIM study – the largest yet – to define & hone “industry standard” practice
Stakeholders across the global Life Sciences industry & regulatory provider community are invited to play their part in cementing the ultimate approach to regulatory information management 4 October 2023 --...
Category: Other
Posted: October 5, 2023
TekniPlex Hires Rahul Goturi as Chief Information Officer
Executive-level move coincides with retirement of longtime CIO Jeff Rishel Goturi brings more than 15 years of CIO experience at global organisations 4 October 2023 -- Ohio, US -- TekniPlex,...
Category: Manufacturing and Packing
Posted: October 4, 2023
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515
FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer
4 October 2023 -- Hillerød, Denmark -- FUJIFILM Diosynth Biotechnologies president and CEO Lars Petersen today announced a new strategic leadership appointment to support the company through its next growth...
Category: Biotechnology
Posted: October 4, 2023
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company’s Combination Vaccine Against Influenza and COVID-19
mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccines Company to begin phase 3 trial of mRNA-1083 in adults...
Category: Clinical Trials, Drug Discovery
Posted: October 4, 2023
Evonetix places first DNA synthesis development platform at Imperial College London
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialisation 4 October 2023 -- Cambridge, UK -- EVONETIX,...
Category: Drug Discovery
Posted: October 4, 2023
Vertex Presents Positive, Updated VX-880 Results From Ongoing phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
All patients treated with VX-880 in Parts A and B have follow-up data beyond Day 90 and have demonstrated islet cell engraftment and glucose-responsive insulin production All patients showed improvement...
Category: Clinical Trials
Posted: October 4, 2023
Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies
Sponsored PhD student will join Professor Ed Tate’s group at Imperial College London, UK, in the EPSRC Centre for Doctoral Training in Chemical Biology Project aims to develop the next...
Category: Biotechnology, Drug Discovery
Posted: October 4, 2023
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation
Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...
Category: Biotechnology
Posted: October 4, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
DSM-FIRMENICH TO DEBUT AT CPHI, SHARING ITS VISION FOR PURPOSE-POWERED SOLUTIONS FOR THE PHARMACEUTICAL INDUSTRY
3 October 2023 – Kaiseraugst, Switzerland – Following the merger of two iconic companies – DSM and Firmenich – in May 2023, dsm-firmenich will make its debut at CPHI Barcelona...
Category: BioManufacturing, Pharmaceutical
Posted: October 4, 2023
